Brain Cancer & Neuro-Oncology
The Neuro-Oncology Center at The Angeles Clinic and Research Institute offers comprehensive treatment services for primary central nervous system cancer. Our Neuro-Oncology Director, Dr. Omid Hamid leads a team of physicians who are dedicated to the principle of comprehensive patient care - working together to guide each patient through cancer diagnosis, treatment, and recovery. Treatment plans reflect the combined expertise of neurosurgeons, neuro-oncologists, neurologists, neuroradiologists, radiation oncologists, and experienced neuropathologists; ensuring that patients will receive the best possible therapy and latest options for primary brain cancer, including glioblastoma, oligodendroglioma, or ependymoma. Learn more about the Brain Tumors Collaborative Clinical Trials.
Brain tumors are a rare condition that results when cells grow abnormally and form a mass. Brain tumors may originate in the brain or spread from cancer in another part of the body. There are many different types of brain tumors. Brain tumors can directly destroy or indirectly damage brain cells. The affects of a brain tumor may be temporary or permanent. Brain tumors may be treated with surgery, radiation therapy, chemotherapy, biological therapies, or a combination of treatments. Learn more about brain tumors.
Learn more about the Brain Tumors Collaborative Clinical Trials.
Spinal Cord Tumors
Spinal cord tumors may originate in the spinal cord or result from the spread of cancer from another location in the body. Your spinal cord transmits sensory, movement, and reflex information between your brain and body. Spinal cord tumors need prompt treatment to prevent serious complications including disability, paralysis, or death. Spinal cord tumors can be treated with medications, surgery, radiation, or a combination of treatments. Learn more about spinal cord tumors.
The Angeles Clinic and Research Institute’s Neuro-Oncology Center's highly-skilled, multidisciplinary team of physicians and specially trained nurses remain at the forefront of oncologic therapy, participating in national cooperative group trials, multi-center academic trials, and our own investigator-initiated protocols. Patients with brain cancer, including glioblastoma, oligodendroglioma, and epenymom receive the latest, most advanced medical treatment tailored to meet their individual tumor profile needs, such as MGMT tumor evaluation.
Learn more about the Brain Tumor Collaborative Clinical Trials.